Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_assertion type Assertion NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_head.
- NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_assertion description "[Clinical usefulness of a panel of beta2 integrins in accurate prediction of acute promyelocytic leukemia and recommendation of inclusion to identify patients who require retinoic acid therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_provenance.
- NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_assertion evidence source_evidence_literature NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_provenance.
- NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_assertion SIO_000772 16764927 NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_provenance.
- NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_assertion wasDerivedFrom lhgdn-20090331 NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_provenance.
- NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_assertion wasGeneratedBy ECO_0000203 NP217687.RAed3ameASew2PoNnXwPIjbHUxUzeB7p9ZMX8ER3IWRLY130_provenance.